This ADC product is comprised of a Protein A conjugated via a linker to Duocarmycin. The Duocarmycin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, Duocarmycin binds
* VAT and and shipping costs not included. Errors and price changes excepted